ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals, Inc. (SPRY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SPRY · as of Jun 9, 2026
Key Statistics
Explore ARS Pharmaceuticals, Inc. Data
spry stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 10 · Buy rate: 40.0%
The SPRY analyst consensus is Hold, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month price target is $25.50, representing +183.65% upside from the current price of $8.99.
Competitors & Peers
spry competitorsSPRY
ABUS
GHRS
KURA
LENZ
NBTXStock Performance
Full HistoryAbout ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals, Inc. specializes in creating ARS-1, an innovative intranasal epinephrine spray utilizing advanced absorption technology. This product serves as a crucial intervention for individu…
what is ars pharmaceuticals, inc. · spry stock overview · ars pharmaceuticals, inc. company profile · who is ars pharmaceuticals, inc. ceo · spry NASDAQ · ars pharmaceuticals, inc. headquarters · ars pharmaceuticals, inc. business segments
About Stock Overview & Key Data
ARS Pharmaceuticals, Inc. (SPRY) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 4, 2020. As of the latest trading session, SPRY stock price is $8.99, with a market capitalization of $892.7M. The stock has returned -38.13% over the past 12 months and -22.83% year-to-date.
According to 10 Wall Street analysts, the consensus rating for ARS Pharmaceuticals, Inc. stock is Hold, with an average 12-month price target of $25.50. In fiscal year 2025, ARS Pharmaceuticals, Inc. reported revenue of $84.3M and net income of -$171.3M. For detailed data — including ARS Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, ARS Pharmaceuticals, Inc. (SPRY) stock price is $8.99. The stock is traded on NASDAQ under the ticker symbol SPRY. The 52-week range is $6.66 – $18.90.